ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

6,583Medicare Part D Prescriptions Filled, Including Refills

Rank: 98 out of 223

$408K Total Retail Price of All Prescriptions

Rank: 93 out of 223

296 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
12% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Utah
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 296 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

14% of this provider’s 296 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

2% of this provider’s 6,086 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$62 was the average price of a prescription from this provider, compared to $62 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Utah
SIMVASTATIN 343 338 1 1
OMEPRAZOLE 236 232 2 3
AMLODIPINE BESYLATE 213 202 3 6
LEVOTHYROXINE SODIUM 191 170 4 2
HYDROCODONE-ACETAMINOPHEN 188 162 S3 5 5
LISINOPRIL 163 157 6 4
ZOLPIDEM TARTRATE 141 130 7 8
HYDROCHLOROTHIAZIDE 134 134 8 13
TRAZODONE HCL 127 102 9 22
GABAPENTIN 115 109 10 10
TRAMADOL HCL 113 113 11 18
WARFARIN SODIUM 96 96 12 11
LOSARTAN POTASSIUM 91 90 13 14
LOSARTAN-HYDROCHLOROTHIAZIDE 90 90 14 31
NEXIUM 86 65 15 49
SYNTHROID 85 76 16 35
CARVEDILOL 83 79 17 23
CELEBREX 77 76 18 42
METFORMIN HCL ER 76 71 19 41
FENOFIBRATE 75 63 20 38
GLIMEPIRIDE 74 74 21 30
SERTRALINE HCL 71 71 22 21
TAMSULOSIN HCL 71 71 22 26
PREDNISONE 68 66 24 43
FLUOXETINE HCL 68 66 24 24
FUROSEMIDE 67 66 26 9
MELOXICAM 67 66 26 33
ALLOPURINOL 66 66 28 28
CITALOPRAM HBR 66 50 28 16
FLUTICASONE PROPIONATE 64 50 30 27
BENAZEPRIL HCL 64 64 30 57
ROPINIROLE HCL 57 57 32 62
METOPROLOL TARTRATE 56 56 33 25
NAMENDA 56 56 33 48
PRAVASTATIN SODIUM 54 41 35 15
LANTUS 54 46 35 34
LISINOPRIL-HYDROCHLOROTHIAZIDE 53 39 37 29
METFORMIN HCL 52 48 38 7
METOPROLOL SUCCINATE 51 51 39 20
AMLODIPINE BESYLATE-BENAZEPRIL 51 49 39 105
CYMBALTA 50 41 41 40
POTASSIUM CHLORIDE 50 49 41 12
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 24, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.